172 related articles for article (PubMed ID: 36333819)
1. Livedoid vasculopathy and peripheral neuropathy: A retrospective cohort study of 55 Chinese patients and literature review.
Gao Y; Jin H
Int Wound J; 2023 May; 20(5):1498-1505. PubMed ID: 36333819
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Peripheral Neuropathy in Patients With Livedoid Vasculopathy.
Eswaran H; Traub R; Googe P; Moll S
J Clin Neuromuscul Dis; 2023 Mar; 24(3):157-161. PubMed ID: 36809203
[TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of skin lesions in livedoid vasculopathy: a study of 46 Chinese patients.
Zhao C; Jing K; Feng S
Int J Dermatol; 2023 Feb; 62(2):212-216. PubMed ID: 36411590
[TBL] [Abstract][Full Text] [Related]
4. Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases.
Tubone MQ; Escobar GF; Peruzzo J; Schestatsky P; Maldonado G
An Bras Dermatol; 2013; 88(6 Suppl 1):227-9. PubMed ID: 24346927
[TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy and livedoid vasculopathy.
Soulages A; Maisonobe T; Auzou P; Petit A; Allenbach Y; Barète S; Skopinski S; Ribeiro E; Jullié ML; Lamant L; Brevet F; Soulages X; Vallat JM; Martin-Négrier ML; Solé G; Duval F; Carla L; Le Masson G; Mathis S
J Neurol; 2022 Jul; 269(7):3779-3788. PubMed ID: 35166926
[TBL] [Abstract][Full Text] [Related]
6. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
Osada S; Kimura Y; Kawana S
J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
[TBL] [Abstract][Full Text] [Related]
7. Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.
Gardette E; Moguelet P; Bouaziz JD; Lipsker D; Dereure O; Le Pelletier F; Lok C; Maisonobe T; Bessis D; Conard J; Francès C; Barete S
Acta Derm Venereol; 2018 Oct; 98(9):842-847. PubMed ID: 29738044
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
[TBL] [Abstract][Full Text] [Related]
9. Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: Clinical, histopathological and therapy evaluation.
Criado PR; Pagliari C; Morita TCAB; Marques GF; Pincelli TPH; Valente NYS; Garcia MSC; de Carvalho JF; Abdalla BMZ; Sotto MN
Dermatol Ther; 2021 Mar; 34(2):e14810. PubMed ID: 33496999
[TBL] [Abstract][Full Text] [Related]
10. Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment.
El Khoury J; Taher A; Kurban M; Kibbi AG; Abbas O
Int Wound J; 2012 Jun; 9(3):344-7. PubMed ID: 22044499
[TBL] [Abstract][Full Text] [Related]
11. Expanding the spectrum of livedoid vasculopathy: peculiar neuromuscular manifestations.
Allenbach Y; Tourte M; Stenzel W; Goebel HH; Maisonobe T; Frances C; Barete S; Benveniste O
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):849-52. PubMed ID: 25871345
[No Abstract] [Full Text] [Related]
12. Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy.
Espinel DPGS; Di Giacomo TB; Pincelli TP; Pereira NV; Sotto MN; Kirsner RS; Criado PR
J Cutan Pathol; 2017 Dec; 44(12):1033-1037. PubMed ID: 28901563
[TBL] [Abstract][Full Text] [Related]
13. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol.
Criado PR; de Souza EspinelI DP; Valentef NS; Alavi A; Kirsner RS
Dermatol Ther; 2015; 28(4):248-53. PubMed ID: 25824252
[TBL] [Abstract][Full Text] [Related]
14. Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review.
Kim EJ; Yoon SY; Park HS; Yoon HS; Cho S
Dermatol Ther; 2015; 28(5):287-90. PubMed ID: 25845419
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis.
Weishaupt C; Strölin A; Kahle B; Kreuter A; Schneider SW; Gerss J; Eveslage M; Drabik A; Goerge T
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1784-1791. PubMed ID: 31009111
[TBL] [Abstract][Full Text] [Related]
16. Livedoid vasculopathy: clinical features and treatment in 24 Chinese patients.
Feng S; Su W; Jin P; Shao C
Acta Derm Venereol; 2014 Sep; 94(5):574-8. PubMed ID: 24352295
[TBL] [Abstract][Full Text] [Related]
17. Homeopathic treatment in resistant livedoid vasculopathy: case report.
Waisse-Priven S; Jurj G; Lima Thomaz LC; Tierno SA; Filho WL; Sos AB
Homeopathy; 2009 Jul; 98(3):165-8. PubMed ID: 19647211
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features of peripheral neuropathy with livedo reticularis: an analysis of seven cases].
Cao YL; Sun C; Xi JY; Luo SS; Hu JN; Zheng YS; Qiao K; Lu JH; Lin J
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(3):218-221. PubMed ID: 38220448
[TBL] [Abstract][Full Text] [Related]
19. Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy.
Alix JJ; Hadjivassiliou M; Ali R; Slater D; Messenger AG; Rao DG
Muscle Nerve; 2015 Feb; 51(2):296-301. PubMed ID: 25196820
[TBL] [Abstract][Full Text] [Related]
20. Livedoid vasculopathy - a thrombotic disease.
Kerk N; Goerge T
Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
